Reach Our Protein Experts:

appliedproteinservices@lonza.com

Improve Your Biological Development Success

The Applied Protein Services (APS) platform is effective at improving the developablity and manufacturability: quality, safety, and efficacy  of antibodies, therapeutic proteins, peptides and vaccines. By supporting the successful risk assessment, selection, optimization and early process development of promising drug candidates, Lonza’s Applied Protein Services improves your likelihood of hitting your target each time.

 

 

Core Technologies

We offer a complete line of in silico and in vitro services for developability, immunogenicity, stability, humanization, and protein engineering.  These technologies include our award winning and patented Epibase® T-cell epitope screening platform along with our proprietary technology platform for structural protein engineering.

To read more about our in silico and in vitro platforms, download our Applied Protein Services Brochure. 

APS Product Applications:                   
     

  • Antibodies
  • Therapeutic Proteins
  • Peptides
  • Vaccines 

 Customer Benefits:

  • Mitigate Risks
  • Reduce Attrition
  • Improve Quality and Safety
  • Increase Efficacy and Manufacturibility

Discovery Phase Material Supply Services (mg to kg)

Our goal at Lonza is to offer you a complete service portfolio for your early discovery and development needs.  In addition to our full range of protein analysis services, we also offer a new custom supply service for mg to kg quantities of both GMP and non-GMP material.

The new streamlined and minimal scope development and manufacturing services, called Light Path™, are available for both mammalian and microbial applications.  Light Path™ programs have been designed by our Mammalian R&D Services experts who have used their years of experience and optimization to create a set of minimal scope processes to achieve your early project goals.